NCT06134544View on ClinicalTrials.gov

Effect of IMO on Intestinal Microbiota Translocation in Cirrhosis

NARecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 25, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

July 1, 2024

Conditions
Decompensated Cirrhosis
Interventions
DIETARY_SUPPLEMENT

Isomaltooligosaccharides (IMO)

Patients will still receive standard treatment, including medicine and other invasive treatment.

Trial Locations (1)

Unknown

RECRUITING

Nanfang Hospital, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER